[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Minimal Invasive and Non Invasive Product and Service Market (2009 - 2014)

September 2009 | 179 pages | ID: M1B8BFBD47FEN
MarketsandMarkets

US$ 3,955.00 US$ 5,650.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The healthcare industry has recently witnessed the adoption of many new technologies that increase the efficiency of various medical treatments. Minimally invasive surgery (MIS) is one of the most important developments among all such cutting-edge medical technologies. This report uses the term ‘minimally invasive surgery’ to include non-invasive surgeries as well. The increasing demand of specialized treatment has propelled the market growth for MIS; and many companies – especially the new entrants from developing nations – are competing to benefit out of the rapid growth of this market.

With its progressive technological advancements such as capsule endoscopy and drug eluting stent, the MIS market is set to evolve due to the increasing demand for patient convenience, such as painless treatment and reduced post-operative stay. The MIS market has a current potential of $16.4 billion and is expected to grow at a CAGR of 8.3% between 2009 and 2014. The U.S. holds the major share of the global MIS market; and the growth of the U.S. market is driven by its growing ageing population and improvements in MIS technologies.

Market estimates and forecasts

The report provides in-depth market estimates and forecast for global minimally invasive/non-invasive market as follows:

• MIS market – products
Surgical devices, monitoring and visualization systems, endosurgical equipment, medical robotics, and electrosurgical equipment

• MIS market – application
Gastrointestinal surgery, gynecological surgery, urological surgery, cosmetic surgery, obesity surgery, thoracic surgery, cardiac surgery, vascular surgery, orthopaedic surgery, and other surgery

• MIS market – technology
Transcatheter surgery, laparoscopy, non-visual imaging, and medical robotics

• MIS market – end user
Hospital surgical departments, outpatient surgery centers, group practices, individual surgeons, medical schools, and other users

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.

• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies - US, Europe, APAC, ROW.

• We provide 10% customization - Research shows that more than 40% of the times, clients do not get the specific intelligence they need in multi-client market research reports. We offer 10% customization in our reports at no extra cost. Get the exact market intelligence you require with real value for money.

• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

• Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?

- What are market estimates and forecasts; which markets are doing well and which are not?

- Where are the gaps and opportunities; what is driving the market?

- Which are the key playing fields? Which are the winning edge imperatives?

- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

1. INTRODUCTION

1.1. KEY TAKE AWAYS
1.2. MARKETS COVERED
1.3. STAKEHOLDERS
  1.3.1. MINIMALLY/NON-INVASIVE SURGICAL EQUIPMENT MANUFACTURING COMPANIES
  1.3.2. HOSPITAL SURGICAL DEPARTMENTS AND INDIVIDUAL SURGEONS
  1.3.3. OUTPATIENT SURGERY CENTERS
  1.3.4. BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS

2. SUMMARY

3. MARKET OVERVIEW

3.1. EVOLUTION OF THE MINIMALLY INVASIVE SURGERY MARKET
  3.1.1. MINIMALLY INVASIVE SURGERY VS CONVENTIONAL OPEN SURGERY
3.2. THE FUTURE OF MINIMALLY INVASIVE SURGERY
3.3. DEFINING THE MINIMALLY INVASIVE SURGERY MARKET
3.4. DEFINING THE MINIMALLY INVASIVE PRODUCT MARKET
3.5. DEFINING THE MINIMALLY INVASIVE APPLICATION MARKET
3.6. DEFINING THE MINIMALLY INVASIVE TECHNOLOGY MARKET
3.7. DEFINING THE MINIMALLY INVASIVE END-USER MARKET
3.8. MARKET DRIVERS FOR MINIMALLY INVASIVE SURGERY MARKET
  3.8.1. INCREASE IN AGING POPULATION BOOSTS THE DEMAND FOR SURGERIES
  3.8.2. INCREASE IN AWARENESS AND DEMAND FOR PATIENT-FRIENDLY OPERATING METHODS
  3.8.3. MINIMALLY INVASIVE SURGERY HELPS REDUCE HEALTHCARE COST
3.9. RESTRAINTS FOR THE MINIMALLY INVASIVE SURGERY MARKET
3.10.OPPORTUNITIES IN THE MINIMALLY INVASIVE SURGERY MARKET
  3.10.1. HUGE MARKET SIZE ATTRACTING NEW ENTRANTS IN MINIMALLY INVASIVE MARKET
  3.10.2. PHYSICIANS ARE SETTING A STRONG FOUNDATION FOR THE FUTURE OF MINIMALLY INVASIVE SURGERY MARKET

4. MINIMALLY INVASIVE PRODUCT MARKET

4.1. SURGICAL DEVICES
  4.1.1. MARKET DRIVERS
    4.1.1.1. Innovative marketing model boosting the demand for mis instruments
    4.1.1.2. Increasing number of mis procedures is boosting the demand for mis instruments
  4.1.2. HAND INSTRUMENTS
  4.1.3. FORCEPS/GRASPERS/DISSECTORS
  4.1.4. SCISSORS
  4.1.5. INSUFFLATORS
    4.1.5.1. Developments
  4.1.6. POWER SURGICAL INSTRUMENTS
  4.1.7. OTHER SURGICAL DEVICES
4.2. MONITORING AND VISUALIZATION SYSTEMS
  4.2.1. MARKET DRIVERS
  4.2.2. CAMERAS AND VIDEO SUPPORT
  4.2.3. OTHER MONITORING AND VISUALIZATION MARKET
4.3. ELECTROSURGICAL AND AUXILIARY EQUIPMENT
  4.3.1. LASERS
    4.3.1.1. Drivers
  4.3.2. OTHER MARKET
4.4. ENDOSURGICAL EQUIPMENT
  4.4.1. MARKET DRIVERS
  4.4.2. ENDOSCOPES AND OTHER ENDOSURGICAL EQUIPMENT
4.5. MEDICAL ROBOTICS
  4.5.1. MARKET DRIVERS
    4.5.1.1. Improved surgical results attracting more patients
    4.5.1.2. Medical robotics increase hospital revenue
  4.5.2. SURGICAL NAVIGATION SYSTEMS
  4.5.3. SURGICAL ROBOTS
    4.5.3.1. Drivers
  4.5.4. DIGITAL OPERATING ROOMS
  4.5.5. OTHERS

5. MINIMALLY INVASIVE SURGERY MARKET BY APPLICATION

5.1. COSMETIC SURGERY
  5.1.1. DRIVERS
  5.1.2. PLASTIC SURGERY
  5.1.3. BREAST SURGERY
  5.1.4. OBESITY SURGERY
    5.1.4.1. Drivers
      5.1.4.1.1. Increasing incidence of obesity is driving the bariatric surgery market
      5.1.4.1.2. Increase in awareness of obesity as a dangerous disease
  5.1.5. HAIR REMOVAL
    5.1.5.1. Drivers and restraints
5.2. GASTROINTESTINAL SURGERY
  5.2.1. MARKET DRIVERS
5.3. GYNECOLOGICAL SURGERY
  5.3.1. HYSTERECTOMIES
5.4. UROLOGICAL SURGERY
5.5. THORACIC SURGERY
5.6. CARDIAC SURGERY
  5.6.1. DRIVERS
    5.6.1.1. Technology developments are boosting the cardiac surgery market
    5.6.1.2. New and improved surgical procedures driving the market growth for cardiac surgery
  5.6.2. ROBOT-ASSISTED CARDIAC SURGERY
5.7. VASCULAR SURGERY
5.8. ORTHOPEDIC SURGERY
  5.8.1. JOINT REPLACEMENT
  5.8.2. SPINAL SURGERY
  5.8.3. OTHER SURGERIES

6. MINIMALLY INVASIVE SURGERY MARKET-BY TECHNOLOGY

6.1. NON-VISUAL IMAGING
  6.1.1. OPTICAL IMAGING
    6.1.1.1. Market Drivers
  6.1.2. NON-OPTICAL IMAGING
  6.1.3. HYBRID IMAGING
6.2. MEDICAL ROBOTICS
  6.2.1. MARKET DRIVERS
    6.2.1.1. Improved Surgical Results Attracting Patients
    6.2.1.2. Cost effectiveness Attracting Medical Facilities
6.3. TRANSCATHETER SURGERY
  6.3.1. PERCUTANEOUS ABLATION
  6.3.2. RADIOFREQUENCY ABLATION
    6.3.2.1. Market Drivers
      6.3.2.1.1. Increasing Consumer Base Driving the Market Growth for RFA
      6.3.2.1.2. RFA Gives More Effective Results for Treatment of Liver Tumor
      6.3.2.1.3. Most Promising Nonsurgical Ablation for Breast Cancer Treatment
    6.3.2.2. Restraints
    6.3.2.3. Developments
  6.3.3. MICROWAVE ABLATION
    6.3.3.1. Market Drivers
      6.3.3.1.1. Microwave Ablation Takes Lesser Time for Operating Tumors
      6.3.3.1.2. Microwave Ablation Involves Faster Generation of Heat
6.4. LAPAROSCOPIC SURGERY

7. MINIMALLY INVASIVE SURGERY MARKET BY END-USERS

7.1. HOSPITAL SURGICAL DEPARTMENTS
  7.1.1. MARKET DRIVERS
7.2. OUTPATIENTS SURGERY CENTER
  7.2.1. MARKET DRIVERS
7.3. GROUP PRACTICES
7.4. INDIVIDUAL SURGEONS
7.5. MEDICAL SCHOOLS
7.6. OTHER USERS

8. MINIMALLY INVASIVE SURGERY PATENT ANALYSIS

9. MINIMALLY INVASIVE SURGERY MARKET COMPANY PROFILES

9.1. ABBOTT LABORATORIES
  9.1.1. OVERVIEW
  9.1.2. STRATEGIES AND DEVELOPMENTS
9.2. AESCULAP (A SUBSIDIARY OF B. BRAUN)
  9.2.1. OVERVIEW
  9.2.2. STRATEGIES AND DEVELOPMENTS
9.3. ARTHROCARE CORP.
  9.3.1. OVERVIEW
  9.3.2. STRATEGY AND DEVELOPMENTS
9.4. BIOMET, INC.
  9.4.1. OVERVIEW
  9.4.2. DEVELOPMENTS
9.5. DEPUY SPINE
  9.5.1. OVERVIEW
  9.5.2. STRATEGIES AND DEVELOPMENTS
9.6. DISC-O-TECH MEDICAL TECHNOLOGIES LTD
  9.6.1. OVERVIEW
9.7. ALPHATEC SPINE
  9.7.1. OVERVIEW
  9.7.2. STRATEGIES AND DEVELOPMENTS
9.8. GIVEN IMAGING
  9.8.1. OVERVIEW
  9.8.2. STRATEGIES AND DEVELOPMENTS
9.9. HANSEN MEDICAL
  9.9.1. OVERVIEW
  9.9.2. STRATEGIES AND DEVELOPMENTS
9.10. INTEGRA LIFESCIENCES
  9.10.1. OVERVIEW
  9.10.2. STRATEGIES AND DEVELOPMENTS
9.11. MENTICE MEDICAL SIMULATION
  9.11.1. OVERVIEW
  9.11.2. STRATEGY
9.12. NUVASIVE INC.
  9.12.1. OVERVIEW
  9.12.2. DEVELOPMENTS
9.13. OLYMPUS CORPORATION
  9.13.1. OVERVIEW
  9.13.2. STRATEGIES AND DEVELOPMENTS
9.14. SMITH & NEPHEW
  9.14.1. OVERVIEW
  9.14.2. STRATEGIES AND DEVELOPMENTS
9.15. STRYKER CORPORATION
  9.15.1. OVERVIEW
  9.15.2. STRATEGIES AND DEVELOPMENTS
9.16. SYNTHES, INC.
  9.16.1. OVERVIEW
  9.16.2. STRATEGY
9.17. TELEFLEX
  9.17.1. OVERVIEW
  9.17.2. STRATEGIES AND DEVELOPMENTS
9.18. COVIDIEN LTD
  9.18.1.OVERVIEW
  9.18.2.STRATEGIES AND DEVELOPMENTS
9.19. UNITED STATES SURGICAL CORP. (A SUBSIDIARY OF COVIDIAN)
  9.19.1. OVERVIEW
9.20. ZIMMER HOLDINGS INC.
  9.20.1. OVERVIEW
  9.20.2. STRATEGIES
9.21. MEDTRONIC SOFAMOR DANEK
  9.21.1. OVERVIEW
  9.21.2. STRATEGIES
9.22. PENTAX MEDICAL COMPANY
  9.22.1. OVERVIEW
  9.22.2. STRATEGIES AND DEVELOPMENTS
9.23. SURGICAL INNOVATIONS GROUP PLC.
  9.23.1. OVERVIEW
  9.23.2. DEVELOPMENTS
9.24. K2M INC
  9.24.1. OVERVIEW
  9.24.2. DEVELOPMENTS
9.25. BOSTON SCIENTIFIC CORPORATION
  9.25.1. OVERVIEW
  9.25.2. STRATEGIES AND DEVELOPMENTS
  9.25.3. DEVELOPMENTS
9.26. CHARLES RUSSELL BARD INC.
  9.26.1. OVERVIEW
  9.26.2. STRATEGIES AND DEVELOPMENTS
9.27. FUJIFILM CORPORATION
  9.27.1. OVERVIEW
  9.27.2. STRATEGIES AND DEVELOPMENTS
9.28. KARL STORZ ENDOSKOPE BERLIN GMBH & CO
  9.28.1. OVERVIEW
  9.28.2. STRATEGY
9.29. GYRUS ACMI CORP.
  9.29.1. OVERVIEW
9.30. COOPER SURGICAL INC.
  9.30.1. OVERVIEW
  9.30.2. STRATEGIES AND DEVELOPMENTS
9.31. CLARUS MEDICAL LLC
  9.31.1. OVERVIEW
  9.31.2. STRATEGIES
9.32. ETHICON ENDO-SURGERY, INC.
  9.32.1. OVERVIEW
  9.32.2. STRATEGY
9.33. VALLEYLAB
  9.33.1. OVERVIEW
  9.33.2. STRATEGIES
9.34. JOHNSON & JOHNSON INC.
  9.34.1. OVERVIEW
  9.34.2. DEVELOPMENTS
9.35. CONMED CORPORATION
  9.35.1. OVERVIEW
  9.35.2. DEVELOPMENTS
9.36. INTUITIVE SURGICAL INC
  9.36.1. OVERVIEW

APPENDIX

U.S. PATENTS



More Publications